3 ms·
This relationship is pretty similar across different countries. Pick the current point, pick a point with a similar curve, you’ll see differences are at most 2-
by graeme 5y ago
This relationship is pretty similar across different countries. Pick the current point, pick a point with a similar curve, you’ll see differences are at most 2-3x better, often much less so. Much less of an improvement than the quote 20-fold protection against severe disease (95% efficacy)
Those saying “live with it” argue for a removal of NPIs leading to even higher caseloads. If improvement per case is only 2-3x at most then if you go 2-3x past prior peaks the absolute problem is as bad.
I checked the Uk and got 2-3x depending on metric (icu 2x better, hospital and death, 3x)
Denmark is .5-2x better on these metrics from prior peak.
Germany 3x better on deaths (checking prior case peak, December 21st 2020)
Can you find a country which does not have this pattern, where they are actually 10-20x better for a given caseload?
If not, I posit the pattern holds and that this method has some use in predicting future results at a given caseload in a country at European average levels of vaccination, without boosters.
- ant6n 5y agoLast year Delta didn't exist. If you want to see efficacy of vaccination, compare incidence among vaccinated and non-vaccinated (which will be about 4x).
- graeme 5y agoYeah but my point is that people point to relative efficacy when it is absolute reduction which matters. Delta being 2x worse means you need a stronger relative protection. What do you mean by 4x: relative severe disease protection? That would be 75% efficacy, a marked drop from 95% efficacy (20x protection). I think most of the west still has higher severe disease efficacy than that, though Israel fell as low as 80% pre booster.